Invitation to Submit Proposals under Framework Agreements 173/2022, 436/2023, 481/2023, 491/2023, 780/2024, 1077/2024, 1367/2025, 1428/2025 and 1589/2025

This tender invites proposals for the supply of various medications under multiple framework agreements. The agreements include 173/2022 for diverse medications, 436/2023 for medications for the central nervous system, 481/2023 for additional diverse medications, 491/2023 focusing on oncology drugs and immunomodulators, 780/2024 for medications related to the locomotor system and treatments for endocrine diseases and hormones, 1077/2024 for further diverse medications, 1367/2025 for digestive system medications, and 1428/2025 for antipsychotic medications, anesthetics, and others. Interested parties are encouraged to submit their proposals in accordance with the specifications outlined in the respective framework agreements. The procurement process aims to ensure the availability of essential medications across various therapeutic areas, thereby supporting public health initiatives. Proposals must meet the technical and financial requirements specified in the tender documents. The location of the procurement is not explicitly stated, but it is implied that the supplies will be utilized within the public health sector. This tender represents an opportunity for pharmaceutical companies to engage in public procurement and contribute to the healthcare system.

This is a supplies contract in the information and communication technology sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 910.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.